KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Goodwill & Intangibles: 2011-2024

Historic Goodwill & Intangibles for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Dec 2024 value amounting to $638.9 million.

  • Supernus Pharmaceuticals' Goodwill & Intangibles rose 12.99% to $742.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $742.6 million, marking a year-over-year increase of 12.99%. This contributed to the annual value of $638.9 million for FY2024, which is 10.88% down from last year.
  • According to the latest figures from FY2024, Supernus Pharmaceuticals' Goodwill & Intangibles is $638.9 million, which was down 10.88% from $716.9 million recorded in FY2023.
  • In the past 5 years, Supernus Pharmaceuticals' Goodwill & Intangibles ranged from a high of $902.2 million in FY2021 and a low of $442.3 million during FY2020.
  • In the last 3 years, Supernus Pharmaceuticals' Goodwill & Intangibles had a median value of $716.9 million in 2023 and averaged $725.1 million.
  • As far as peak fluctuations go, Supernus Pharmaceuticals' Goodwill & Intangibles surged by 1,680.41% in 2020, and later decreased by 12.52% in 2023.
  • Supernus Pharmaceuticals' Goodwill & Intangibles (Yearly) stood at $442.3 million in 2020, then soared by 104.00% to $902.2 million in 2021, then dropped by 9.17% to $819.5 million in 2022, then decreased by 12.52% to $716.9 million in 2023, then fell by 10.88% to $638.9 million in 2024.